Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Nov 12, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genmark Diagnostics Senior VP of Commercial Operations John Bellano has resigned, the company said in a filing with the US Securities and Exchange Commission this week.

Bellano's responsibilities will be divided among Jennifer Williams, who has been promoted to senior VP of global operations; Jeff Hawkins, who has been promoted to senior VP of marketing and business development; and Mike Gleeson, who has been promoted to VP of US sales. Hawkins formerly worked at Third Wave Technologies, Hologic, Abbot Laboratories, and Sysmex.

Foundation Medicine has tapped Maureen Cronin to take over the newly created position of senior VP of research and product development. Cronin formerly led R&D at Genomic Health, where she worked to develop clinical diagnostic tests for specific clinical indications based on genomic biomarkers.

SRI International has appointed Joseph Perrone to lead its molecular diagnostic efforts in its Center for Advanced Drug Research. Perrone formerly was VP of the Technology Transfer Office at the University of Maryland Biotechnology Institute and he served at Becton Dickinson as an R&D team manager.

Jamie Nicholls has been elected chairman of Cold Spring Harbor Laboratory's board of trustees. Nicholls, who formerly was a general partner at Forstmann Little & Co., will replace retiring Chairman Eduardo Mestre. Nicholls also serves on the board of overseers at Memorial Sloan-Kettering Cancer Center.

The board also elected several new officers including Robert Lindsay, co-managing partner at Lindsay Goldberg, and The Simons Foundation President Marilyn Simons, who both will serve as vice chairs; Topspin Partners CEO Leo Guthart was elected treasurer, and Ed Travaglianti, president of TD Bank, was re-elected as secretary; and Dinakar Singh, who is founding partner of TPG-Axon Capital, was elected a new member of the CSHL board of trustees.

GenomeQuest has appointed Henk Heus to lead the company's new personalized medicine research (PMR) program and will manage its steering committee and collaborative sessions. Heus will be joined in the PMR by GenomeQuest Scientific Advisors Richard Wilson, a professor of genetics and director of the Genome Center at Washington University School of Medicine, and Mark Boguski, from the department of pathology at Beth Israel Deaconess Medical Center and the Harvard Medical School Center for Biomedical Informatics.

The Genetics Society of America has elected Philip Hieter of the University of British Columbia to be VP of its board of directors, and it has elected Bonnie Bartel, Judith Berman, and Jeannie Lee to serve on its board in 2011.

Bartel is a professor in the department of Biochemistry and Cell Biology at Rice University; Berman is a professor of Genetics, Cell Biology, and Development at the University of Minnesota; and Lee is an investigator at the Howard Hughes Medical Institute and a professor at Harvard Medical School and the Massachusetts General Hospital.

Tecan Group has appointed heads for its new Life Sciences business segment and its Partnering Business, and it has announced the departure of Matthew Robin, who was head of the Liquid Handling and Robotics business.

Frederic Vanderhaegen, who has worked in management and sales at Millipore, will head its Life Sciences segment, and Bernhard Grob, who was a managing director at Mettler-Toledo, will take over the Partnering Business segment.

Auburn University said this week that molecular biology researcher and the Dean of its College of Sciences and Mathematics Marie Wright Wooten died on Nov. 5. Wooten worked as a post-doctoral associate at the Cold Spring Harbor Laboratory in New York, and she served as acting head of the Department of Zoology and Wildlife and as associate research dean at Auburn before she was dean.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.